Literature DB >> 28549264

Effectiveness of family group conferencing in preventing repeat referrals to child protective services and out-of-home placements.

Dana M Hollinshead1, Tyler W Corwin2, Erin J Maher3, Lisa Merkel-Holguin4, Heather Allan5, John D Fluke6.   

Abstract

Rigorous research on the efficacy of family group conferencing is rare. This randomized control trial study used an intent-to-treat approach to examine whether a referral to a family group conference (FGC) was associated with re-referrals, substantiated re-referrals, or out-of-home placements among child welfare-involved families receiving in-home services. We found no significant associations between treatment and control group assignment and the three outcomes for the sample as a whole. However, families with more children had higher odds of a re-referral and a substantiated re-referral, families with more than one parent had higher odds of re-referral, and families where a substance abuse services referral was noted had higher odds of out-of-home placement. In interaction models with race, we found that families with African American mothers who were referred for an FGC were more likely to be re-referred compared to other families, but no differences were identified with respect to their rates of substantiated re-referrals or out-of-home placements. Implications are discussed.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Child protection; Child welfare outcomes; Family group conferencing; Family preservation; Racial disproportionality; Randomized control trial

Mesh:

Year:  2017        PMID: 28549264     DOI: 10.1016/j.chiabu.2017.04.022

Source DB:  PubMed          Journal:  Child Abuse Negl        ISSN: 0145-2134


  1 in total

1.  Cost-effectiveness of Family Group Conferencing in child welfare: a controlled study.

Authors:  Sharon Dijkstra; Hanneke E Creemers; Francisca J A van Steensel; Maja Deković; Geert Jan J M Stams; Jessica J Asscher
Journal:  BMC Public Health       Date:  2018-07-09       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.